Shield Therapeutics plc
SHIEF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 145.9% | 187.7% | 199.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 46.4% | 30.8% | 44.7% | 35.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -66.1% | -231.5% | -539.6% | -1,234.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -84.5% | -254.4% | -1,094.5% | -1,295.5% |
| EPS Diluted | -0.03 | -0.046 | -0.21 | -0.092 |
| % Growth | 34.9% | 78% | -128.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |